Intravenous glycoprotein IIb/IIIa receptor antagonists reduce mortality after percutaneous coronary interventions. [electronic resource]
Producer: 20030321Description: 26-32 p. digitalISSN:- 0735-1097
- Abciximab
- Angioplasty, Balloon, Coronary -- adverse effects
- Antibodies, Monoclonal -- administration & dosage
- Atherectomy, Coronary -- adverse effects
- Coronary Disease -- etiology
- Eptifibatide
- Female
- Humans
- Immunoglobulin Fab Fragments -- administration & dosage
- Infusions, Intravenous
- Male
- Middle Aged
- Multicenter Studies as Topic
- Myocardial Infarction -- etiology
- Peptides -- administration & dosage
- Platelet Aggregation Inhibitors -- administration & dosage
- Platelet Glycoprotein GPIIb-IIIa Complex -- antagonists & inhibitors
- Postoperative Hemorrhage -- etiology
- Randomized Controlled Trials as Topic
- Risk
- Stents -- adverse effects
- Survival Analysis
- Tirofiban
- Tyrosine -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Meta-Analysis
There are no comments on this title.
Log in to your account to post a comment.